WIDDER KENNETH J - 10 May 2023 Form 4 Insider Report for Evoke Pharma Inc (EVOK)

Role
Director
Signature
/s/ Matthew J. D'Onofrio, Attorney-in-fact for Kenneth J. Widder
Issuer symbol
EVOK
Transactions as of
10 May 2023
Transactions value $
$0
Form type
4
Filing time
11 May 2023, 16:50:44 UTC
Previous filing
08 Jun 2022
Next filing
16 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVOK Stock Option (Right to Buy) Award $0 +14.3K $0.00 14.3K 10 May 2023 Common Stock 14.3K $2.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The total number of shares of common stock subject to the option vests on the one-year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.